Safety of Empagliflozin as Add-on Therapy in Patients with Uncontrolled Type 2 Diabetes Mellitus. Khwaja Yunus Ali Medical College Journal. 2026;16(3):119-122. doi:10.3329/kyamcj.v16i3.88022